New research from the Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN). This summary is based on a paper published in the American Journal of Speech-Language Pathology on January 13, 2026, titled "Language Skills in Patients With Alexander Disease."

Read the paper here. 

Learn more about GLIA-CTN. 

Transcript: 

New research from the Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN), a research group of the Rare Diseases Clinical Research Network.

Investigating Language Skills in Children with Alexander Disease.

This summary is based on a paper published in the American Journal of Speech-Language Pathology on January 13, 2026.

Alexander disease is a rare disorder of the nervous system characterized as a leukodystrophy, a group of disorders affecting the myelin (the fatty coating surrounding nerve fibers). People with Alexander disease may have trouble walking, speaking, and swallowing.

In this study, researchers investigated the relationship between disease characteristics, age, and language skills in patients with Alexander disease. First, the team used clinical and imaging features to determine disease subtypes—including cerebral, intermediate, and bulbospinal—among 82 participants. Next, they used developmentally appropriate tests to assess participants' language and functional communication abilities. Then, they used statistical methods to find differences across groups.

Results showed that overall, cerebral patients experienced the most significant language deficits compared to intermediate and bulbospinal patients. Authors note that these findings can be used to better understand the impact of communication deficits and to provide accommodations and interventions in treatment plans for patients with Alexander disease.